Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ibrutinib in Steroid Refractory Autoimmune Hemolytic Anemia (ISRAEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03827603
Recruitment Status : Recruiting
First Posted : February 1, 2019
Last Update Posted : February 1, 2019
Sponsor:
Information provided by (Responsible Party):
Eugene Nikitin, Association of Oncological Hematologists

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : September 30, 2019
Estimated Study Completion Date : March 31, 2020